Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Xiaoling Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1349-2334; OpenAlex author ID A5078085986. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 5

  1. Targeting Mesothelin Enhances Personalized Neoantigen Vaccine Induced Antitumor Immune Response in Orthotopic Pancreatic Cancer Mouse Models. Co-author DOI 10.1002/advs.202407976↗
  2. Photothermal therapy combined with a STING agonist induces pyroptosis, and gasdermin D could be a new biomarker for guiding the treatment of pancreatic cancer. Last author DOI 10.1186/s12967-025-06247-2↗
  3. Interventional Photothermal Therapy Enhanced Brachytherapy: A New Strategy to Fight Deep Pancreatic Cancer. Co-author DOI 10.1002/advs.201801507↗
  4. The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer. Last author DOI 10.2147/ott.s141245↗
  5. A Comparative Study of Clinical Intervention and Interventional Photothermal Therapy for Pancreatic Cancer. Co-author DOI 10.1002/adma.201700448↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaolong Liu · 1 shared paper, 2025 · strength 0.23
  2. Haijun Yu · 1 shared paper, 2025 · strength 0.23
  3. Zhixiong Cai · 1 shared paper, 2025 · strength 0.23
  4. Yanyan Hu · 1 shared paper, 2025 · strength 0.22
  5. Yanyan Hu · 3 shared papers, 2017–2019 · strength 0.22
  6. Ping Liang · 2 shared papers, 2017–2018 · strength 0.14
  7. Fengrong Zhang · 2 shared papers, 2017–2019 · strength 0.14
  8. Huiyu Liu · 2 shared papers, 2017–2019 · strength 0.14
  9. Xianlin Han · 1 shared paper, 2019 · strength 0.08
  10. Jie Tian · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.